Steris PLC (N:STE)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: Block a Riverside IV
70 Sir John Rogerson's Quay
DUBLIN 2
Tel: 1-440-3927245
Website: N/A
IR: N/A
<
Key People
N/A    
Business Overview
Steris plc, formerly Steris Ltd, is a provider of infection prevention and other procedural products and services. The Company offers a mix of capital equipment products, such as sterilizers and washers, surgical tables, lights and equipment management systems and connectivity solutions, such as operating room integration; consumable products, such as detergents and gastrointestinal endoscopy accessories and other products; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory services and outsourced reprocessing. The Company operates through four reportable business segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. It's Corporate and other segment includes the Defense and Industrial business unit. The Company serves the customers in the United Kingdom, the United States and many other countries throughout the world.
Financial Overview
For the three months ended 30 June 2019, Steris PLC revenues increased 9% to $696.8M. Net income increased 21% to $84.6M. Revenues reflect Applied Sterilization Technologies segment increase of 11% to $154.3M, Health speciality services segment increase of 11% to $135.9M, United States segment increase of 14% to $511.2M, Ireland segment increase of 20% to $15.1M.
Employees: 12,000 as of Mar 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $13,545M as of Jun 30, 2019
Annual revenue (TTM): $2,840M as of Jun 30, 2019
EBITDA (TTM): $640.14M as of Jun 30, 2019
Net annual income (TTM): $318.65M as of Jun 30, 2019
Free cash flow (TTM): $221.22M as of Jun 30, 2019
Net Debt Last Fiscal Year: $971.94M as of Jun 30, 2019
Shares outstanding: 84,686,637 as of Aug 2, 2019
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization